It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1984.
1984 | Mumbai, Maharashtra, India | ActiveSynit Drugs Pvt Ltd, a active private limited company, was established on 12 October 1984 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH1984PTC034255. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.66 M.
It upholds a compliant status. Its leadership includes Sharan Uday Asher (Director), Pranabh Dinesh Mody (Director), Sejal Pranabh Mody (Director). Past directors included Bhushan Vijaykumar Sachdev, Shailesh Jagdishchandra Bhavsar, Sharan Uday Asher. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 804,Floor-8,Plot-3/301,4/401,Lodha Supremus, Dr E Moses Road,Worli Nakka,Worli, Mumbai, Maharashtra, 400018.
U24230MH1984PTC034255
034255
12 October 1984
₹5.00 M
₹1.66 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Synit Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharan Uday Asher | Director | 02 Nov 2021 | Current |
| Pranabh Dinesh Mody | Director | 22 Dec 2020 | Current |
| Sejal Pranabh Mody | Director | 02 Nov 2021 | Current |
| Purvi Uday Asher | Director | 22 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Dec 2020 | Past |
| Pramod Abcsdd | Director | 22 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 02 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synit Drugs Pvt Ltd, for the financial year ended 2017, experienced significant growth in revenue, with a 43.56% increase. The company also saw a substantial improvement in profitability, with a 64.18% increase in profit. The company's net worth Soared by an impressive increase of 10.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Synit Drugs had a promoter holding of 29.11% and a public holding of 70.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synit Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synit Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synit Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Synit Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Synit Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Sharan Uday Asher was appointed as a Director was appointed as a Director on 02 Nov 2021 & has been associated with this company since 4 years 29 days . was documented.
The activity Sejal Pranabh Mody was appointed as a Director was appointed as a Director on 02 Nov 2021 & has been associated with this company since 4 years 29 days . was completed.
The activity Pranabh Dinesh Mody was appointed as a Director was appointed as a Director on 22 Dec 2020 & has been associated with this company since 4 years 11 months . was completed.
Purvi Uday Asher was appointed as a Director was appointed as a Director on 22 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
The CIN of Synit Drugs Pvt Ltd is U24230MH1984PTC034255.
Synit Drugs Pvt Ltd is headquartered at 804,Floor-8,Plot-3/301,4/401,Lodha Supremus, Dr E Moses Road,Worli Nakka,Worli, Mumbai, Maharashtra, 400018.
Synit Drugs Pvt Ltd was incorporated on 12 October 1984.
The current directors of Synit Drugs Pvt Ltd are
The primary industry of Synit Drugs Pvt Ltd is Pharma.
Synit Drugs Pvt Ltd is unlisted.
The authorized capital of Synit Drugs Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹1.66 M.
The compliance status of Synit Drugs Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX